ART-Pterostilbene
- Conditions
- Infertility-
- Registration Number
- JPRN-jRCTs031210153
- Lead Sponsor
- Kawamura Kazuhiro
- Brief Summary
The clinical study was terminated without recruitment of eligible patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 0
(1) Infertile female patients undergoing in vitro fertilization
(2) Patients aged 40 years or older at the time of informed consent
(3) Patients attending the outpatient clinic of a collaborating study site
(4) Patients who have received an adequate explanation on study participation and have provided voluntary written informed consent based on full understanding of the explanation
(1) Patients taking supplements other than vitamin D, folic acid, or iron within one menstrual cycle before the start of the study
(2) Unmarried patients who wish to freeze their eggs
(3) Patients where the possible causes of infertility include diabetes mellitus, polycystic ovary, or a partner with severe spermatogenic dysfunction
(4) Patients who have participated in this study in the past
(5) Patients with an allergy to resveratrols
(6) Patients who are considered inappropriate for participation in the study by the investigator or subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method